Tiffany Ardley

Tiffany Wilson Ardley

ASSOCIATE PROFESSOR
EMAIL
PHONE
850-599-3774
OFFICE
College Of Pharmacy - Instruct

 

Office Hours

Fridays (Online) 9:00 AM - 12:00 PM
Others by Appointment

Current Semester Schedule

PHA 3001-301 INTRO TO PHARMACEUTIC SCIENCES (Lecture) – Tu. Th. 1:30 PM - 2:20 PM
PHA 4430-301 PHARMACOMED CHEM I (Lecture) – Mon. Wed. 2:00 PM - 3:50 PM
PHA 4430L PHARMACOMED CHM I LB (Laboratory) – Tue. 11:00 AM - 1:00 PM
PHA 4931-001PROFESSIONAL SEMINAR (Lecture) – Wed. 4:00 PM - 4:55 PM
PHA 6433-301 PHARMACOMED CHEM I (Lecture) – Mon. 12:00 PM - 1:40 PM

About Me

Dr. Tiffany Wilson Ardley attended FAMU on a Presidential Scholarship and earned a BS in Biology and an MS in Medicinal Chemistry. In May of 2003, she made history as the first African American and first woman to earn the Ph.D. in Medicinal Chemistry from FAMU. After a Post Doctoral Fellowship at Howard University and teaching at Albany State University, she returned to FAMU where she teaches various courses in CoPPS, IPH. She served as a Faculty Senator and held the positions of Senate Secretary and Vice President. In 2017 she led the implementation of the BSPS degree program where she is the current Director. This degree is the only one in the state of Florida and the first at an HBCU with a College of Pharmacy. In 2022 she was named the Director of the Office of Undergraduate Research. She is the Principal Investigator for four US Department of Education grants and also leads a cancer drug discovery research laboratory. She has published 20 manuscripts and her research has been presented at over 50 national and international meetings. In 2020 she received a U.S. Patent for an active anti-cancer agent discovered in her research laboratory. In the community she serves as a member of the Board of Directors for PACE for Girls, Inc., and the Tallahassee Trainers Foundation Board. She is a 33 year member of Delta Sigma Theta Sorority, Inc., and has served as the Primary Advisor for the Beta Alpha Chapter at FAMU since 2018.

Areas of Interest

  • Travel
  • Coloring
  • Making jewelry

Education

 
  • B.S. in Biology
    Florida A&M University*1993
  • M.S. in Medicinal Chemistry
    Florida A&M University*1998
  • Ph.D. in Medicinal Chemistry
    Florida A&M University* 2003

Work History

  • Associate Professor of Medicinal Chemistry (8/21 – Present)
    Florida A&M University, Tallahassee, FL
    College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health
  • Assistant Professor of Medicinal Chemistry (7/08 – 7/21)
    Florida A&M University, Tallahassee, FL
    College of Pharmacy & Pharmaceutical Sciences
  • Director, Office of Undergraduate Research (5/22 – Present)
    Florida A&M University, Tallahassee, FL
    University Academic Affairs, Office of the Provost
  • Director, Bachelor of Science in Pharmaceutical Sciences Degree Program (8/22 - Present)
    Florida A&M University, Tallahassee, FL
    College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health
  • Coordinator, Bachelor of Science in Pharmaceutical Sciences Degree Program (8/19 – 7/22)
    Florida A&M University, Tallahassee, FL
    College of Pharmacy & Pharmaceutical Sciences
  • Assistant Director for Undergraduate Studies (7/17 – 8/19)
    Florida A&M University, Tallahassee, FL
    College of Pharmacy & Pharmaceutical Sciences
  • Director of Graduate Studies and Research (8/16 – 6/17)
    Florida A&M University, Tallahassee, FL
    College of Pharmacy & Pharmaceutical Sciences
  • Adjunct Professor of Chemistry (8/05-7/21)
    Tallahassee Community College, Tallahassee, FL
    Department of Science and Math
  • Assistant Professor of Chemistry (8/05-6/08)
    Albany State University, Albany, GA
    Department of Natural Sciences
  • Post Doctoral Research Associate (8/03-5/05)
    Howard University, Washington, DC
    College of Pharmacy Nursing & Allied Health Sciences
    Department of Pharmaceutical Sciences
  • Research Associate (8/93-8/03)
    Florida A&M University, Tallahassee, FL
    College of Pharmacy & Pharmaceutical Sciences

Academic Accomplishments

  • Shasline Gedeon, Aisha Montgomery, Madhavi Gangapuram, Kinfe K. Redda, Tiffany W. Ardley. The Chemistry and Pharmacology of Tetrahydropyridines: Part 2, J. Clinical Medical Reviews and Reports, 2023; 4(5) DOI: 10.31579/2690-8794/135.
  • Henderson ED, Gangapuram M, Eyunni SV, Redda KK, Wilson-Ardley T. Design, Synthesis and Evaluation of Novel N-Substituted-[Benzoylamino]-5-Ethyl1,2,3,6-Tetrahydropyridines as Potential Anti-Cancer Agents. Madridge J Pharm Res. 2019; 3(1): 52-59. doi: 10.18689/mjpr-1000109
  • Clark II, C.J., Ardley, T.W., and Black, J.T. “The Program of Excellence in STEM: Involvement of Traditionally Underrepresented Students in STEM Education Through Research and Mentoring at Florida A&M University”, Proceedings 5th IEEE Integrated STEM Conference, Princeton University; Princeton, NJ; March 7, 2015; pp. 164-168.
  • Yasmeen M. Nkrumah-Elie, Alicia M. Hudson, Equar Taka, Ramesh Badisa, David Bauer, Shanalee S. Gallimore, Bridg’ette Israel, Tiffany Ardley, Ebenezer Oriaku, Ronald D. Thomas*, Selina F. Darling-Reed; The attenuation of benzo(a)pyrene-induced carcinogenic insults by diallyl disulfide (DADS) in MCF-10A cells. Nutrition and Cancer: An International Journal, 64(7); 1112-21(2012)
  • Yasmeen M. Nkrumah-Elie, Alicia M. Hudson, Equar Taka, Ramesh Badisa, Ketia Eugene, Tiffany Ardley, Bridg’ette Israel, Sakeenah Y. Sadrud-Din, Ebenezer Oriaku, Selina F. Darling-Reed: Diallyl trisulfide as an Inhibitor of benzo(a)pyrene-induced Precancerous Carcinogenesis in MCF-10A cells. Food and Chemical Toxicology. 50(7);2524-30 July (2012) 
  • Mohammad A. Ghafari, Tiffany W. Ardley, Madhavi Gangapuram and Kinfe K. Redda. The synthesis of n-Substituted Carbonylamino-1,2,3,6-Tetrahydropyridines as Potential Anti-inflammatory Agents. Synthetic Communications 41:17, 2615-2623, June 29 (2011). To link to this article: http://dx.doi.org/10.1080/00397911.2010.515335. 
  • Bereket Mochona, Laine Le, Madhavi Gangapuram, Nelly Mateeva, Tiffany W. Ardley and Kinfe K. Redda. Synthesis of 2-(N-Benzylpyrrolyl)-benzimidazoles as Potential Anti-inflammatory Agents. Journal of Heterocyclic Chemistry 47(6): 1367-1371, November 1 (2010).
  •  Ivan O. Edafiogho, Samuel B. Kombian, Kettireddy V.V. Anathalaskshmi, Noha N. Salama, Natalie D. Eddington, Tiffany L. Wilson, Mariano S. Alexander, Patrice L. Jackson, Clive D. Hanson, K. R. Scott. Mini Review - Enaminones: Exploring Additional Therapeutic Activities. Journal of Pharmaceutical Sciences, Oct;96(10):2509-3, (2007)DOI 10.1002/jps.20967.
  • Alan J. Anderson, Jesse M. Nicholson, Oladapo Bakare, Ray J. Butcher, Tiffany L. Wilson and K. R. Scott. Enaminones 9. Further Studies on the Anticonvulsant Activity and Potential Type IV Phosphodiesterase Inhibitory Activity of Substituted Vinylic Benzamides. Bioorg. Med. Chem., 14(4), 997-1006 (2006).
  • Tiffany L. Wilson, Patrice L. Jackson, Clive D. Hanson, Z. Xue, Natalie D. Eddington and Kenneth R. Scott. QSAR of The Anticonvulsant Enaminones; Molecular Modeling Aspects and Other Assessments. Medicinal Chemistry, 1(4), 371-381 (2005).
  • Noah Nabil Salama, Natalie D. Eddington, Debra Payne, Tiffany L. Wilson and K.R. Scott. “ Multidrug Resistance and Anticonvulsants: New Studies with Some Enaminones.” Curr. Med. Chem., 11(15), 2093-2103 (2004).
  • T. Wilson and K. Redda, "Synthesis and Anti-inflammatory Activity Determinations of Some N-[Substituted Benzoyl(phenylsulfonyl)amino] -5-Ethyl-1,2,3,6-tetrahydropyridines", Med. Chem. Res.,12 (2), 69-86 (2003). 
  • Mochona, B., Wilson, T. Redda, K. "Synthesis and Anti-Inflammatory Activities of N-Benzoylamino-1,2,3,6-Tetrahydropyridine Analogs." Drugs Under Experimental and Clinical Research, XXIX(4), 131-140 (2003).
  • Okoro, CO, Wilson, TL, Redda, KK. "Conformational Analysis and Molecular Properties of N-(Substituted Phenyl-carbonylamino)-4-(1-Hydroxymethylphenyl)-1,2,3,6-Tetrahydropyridines." Curr. Med. Chem., 10(4):313-330 (2003).

Awards

US PATENTS
  • Use of N-(4-Iodobenzoylamino)-5-ethyl-1,2,3,6-Tetrahydropyridine as a Treatment for Cancer. Elizabeth Henderson, Tiffany Wilson Ardley, Kinfe Redda and Madhavi Gangapuram. US Patent #10,646,479 B2 Issued May 12, 2020.

RESEARCH FUNDING (Active)
  • Minority Science and Engineering Improvement Program (PI). Funded by the United States Department of Education. October 2023-September 2026 ($797,751) P120A230058 Funding for Program of Excellence in STEM MAPS for the enhancement of math skills for 9th-12th grade as well as college freshman and sophomores. 
  • Minority Science and Engineering Improvement Program (Co-PI). Funded by the United States Department of Education. October 2019-September 2024 ($749,217) P120A190038 Funding for Program of Excellence in STEM Enrichment for the training and mentoring in research and recruitment of 9th-12th grades into STEM areas. 
  • Minority Science and Engineering Improvement Program (Co-PI). Funded by the United States Department of Education. October 2019-September 2024 (749, 512) P120A190042 Funding for Program of Excellence in STEM Environmental Education. For the training and mentoring in research and recruitment of 9th-12th graders into the STEM area of Environmental Science.
  • Minority Science and Engineering Improvement Program (Co-PI). Funded by the United Stated Department of Education. October 2019-September 2024 ($749,333) P120A190064 Funding for the Program of Excellence in STEM Environmental Research. For the training and mentor in research of undergraduate and graduate students in the STEM area of Environmental Science.

RESEARCH FUNDING (Completed)
  • Minority Science and Engineering Improvement Program (Co-PI). Funded by the United States Department of Education. October 2016-September 2019 ($721,710) Funding for Program of Excellence in STEM Development for the training and mentoring in research and recruitment of 9th-12th graders into STEM areas.
  • Minority Science and Engineering Improvement Program (Co-PI). Funded by the United States Department of Education. October 2013-December 2016. ($739,240) Funding for Program of Excellence in STEM for high school students and college freshman.
  • Design and Synthesis of Novel Tetrahydropyridines as Anti-Cancer Agents. Funded by the RCMI BRIDGES Program, August 20, 2012-May 31, 2013. ($20,000)
  • Faculty Research Development Program Award – Florida A & M University, November 1, 2010-June 30, 2011 ($10,000) Project title “Synthesis and Biological Evaluation of 2-Pyridones as Potential Agents for the Treatment of Breast Cancer and/or Uterine Fibroids.”
  • Faculty Research Assistance Program – Florida A & M University, August 1, 2010-December 31, 2010. ($4,250) Project title “Pharmacological Activity Determinations of Novel Tetrahydropyridine Derivatives as Potential Prostate Cancer Agents.”
  • Faculty Research Development Program Award – Florida A & M University, November 1, 2009-March 31, 2010 ($10,000) Project title “Synthesis of 2-Pyridones as Potential Agents for the Treatment of Breast Cancer and/or Uterine Fibroids.”
  • Faculty Research Development Program Award – Florida A & M University, November 1, 2008 – May 31, 2009 ($10,500) Project title “Synthesis of Pyridinesulfonicacid Amides as Potential Breast Cancer Agents.”
  • Faculty Development Research Award - Albany State University, January-December 2006, ($10,000) Project title “Synthesis of Tetrahydropyridine Derivatives as Potential Breast Cancer Agents.”

Courses Taught At FAMU

  • PHA 3010 Pharmaceutical Sciences II
  • PHA 3010L Pharmaceutical Sciences II Laboratory
  • PHA 3050 Introduction to Pharmaceutical Sciences
  • PHA 3080 Scientific Communications
  • PHA 3910L Undergraduate Research
  • PHA 3933 Undergraduate Research Seminar
  • PHA 3571 Introduction to Principles of Drug Action
  • PHA 4019 Pharmaceutical Sciences III
  • PHA 4430 Pharmacomedicinal Chemistry I
  • PHA 4430L Pharmacomedicinal Chemistry I Laboratory
  • PHA 4431 Pharmacomedicinal Chemistry II
  • PHA 4431L Pharmacomedicinal Chemistry II Laboratory
  • PHA 4572 Principles of Drug Action I
  • PHA 4572L Principles of Drug Action I Laboratory
  • PHA 4573 Principles of Drug Action II
  • PHA 4931 Professional Seminar
  • PHA 6353 Natural Product Chemistry
  • PHA 6421 Advanced Medicinal Chemistry I
  • PHA 6422 Advanced Medicinal Chemistry II
  • PHA 6433 Graduate Pharmacomedicinal Chemistry I
  • PHA 6434 Graduate Pharmacomedicinal Chemistry II
  • PHA 6446 Special Topics in Medicinal Chemistry
  • PHA 6916 Research Internship
  • PHA 6938 Research Seminar
  • PHA 7979 Advanced Research
  • PHA 7980 Dissertation